Market Research, Feasibility Study and Business Plan for Pharmaceutical Company in Turkey

Establishing a pharmaceutical company in Turkey, with its strategic location and growing healthcare sector, offers significant potential but requires meticulous planning. This comprehensive guide details the essential steps of market research, a feasibility study, and a strategic business plan, and highlights how expert consultancy from Aviaan can ensure your success.
COMMERCIAL EXCELLENCE

Loading...

Strategic guidance and institutional-grade solutions customized for your enterprise objectives.

Talk to a Financial Expert

Schedule a complimentary 30-minute discovery call to discuss your enterprise’s financial trajectory.
By submitting, you agree to our Privacy Policy.

Table of Contents

Turkey’s pharmaceutical sector is a high-growth, strategically important industry characterized by a large and increasing population, evolving public health policies, and a robust local manufacturing base. Positioned at the crossroads of Europe and Asia, the country offers a lucrative gateway for pharmaceutical companies looking to expand their reach. However, entering this highly regulated and competitive market requires a disciplined and detailed approach, starting with comprehensive market intelligence, followed by a rigorous feasibility study, and finalized with a strategic business plan. This critical process is significantly enhanced by partnering with an expert business advisory firm like Aviaan.

A graphic representation of a successful pharmaceutical manufacturing facility in Turkey, showing a clear roadmap from R&D to market entry.

Understanding the Turkish Pharmaceutical Landscape Through Market Research

Market research is the bedrock of any successful pharmaceutical venture in Turkey. It provides the essential data to understand the industry's complex regulatory environment, pricing mechanisms, competitive pressures, and growth opportunities, particularly in the thriving generics and emerging biologics segments.

Analysis of Market Dynamics and Regulatory Environment

The Turkish pharmaceutical market, despite facing challenges like currency volatility and stringent government pricing, remains a strong growth area. A successful market research initiative must deeply analyze:

  • Market Size and Growth: Determine the current value and volume of the Turkish pharmaceutical market. Analyze historical growth rates and project future trends, paying close attention to government healthcare expenditure and public reimbursement systems.
  • Regulatory Framework: The Turkish Medicines and Medical Devices Agency (TITCK) is the main regulatory authority. Understanding the processes for obtaining Manufacturing Licenses, Marketing Authorization (MA), Good Manufacturing Practice (GMP) compliance, and the strict rules on product registration, pharmacovigilance, and clinical trials is non-negotiable.
  • Pricing and Reimbursement: The Social Security Institution (SGK) controls the vast majority of drug purchases. Research must dissect the reference pricing system, public reimbursement lists, and the impact of mandatory localization policies on pricing strategy and profitability.

Identifying Key Segments and Target Markets

The Turkish pharmaceutical market is segmented across several critical areas, each presenting different opportunities:

  • Generics vs. Branded Drugs: Generic drugs dominate the market in terms of volume, driven by government policies promoting cost-effective alternatives. Identifying high-demand generics with limited local production is a key opportunity.
  • Biopharmaceuticals and Specialty Drugs: This is a high-growth segment, fueled by an increasing prevalence of chronic diseases and government focus on innovative treatments. Biosimilars, in particular, present a major investment opportunity.
  • Over-the-Counter (OTC) and Supplements: Growing health awareness and increasing disposable income are boosting the demand for vitamins, minerals, and supplements. Understanding consumer behavior in this self-pay segment is crucial for market entry strategy.
  • Therapeutic Areas: Research should pinpoint the highest-growth therapeutic areas, such as oncology, diabetes, cardiovascular diseases, and central nervous system disorders, to focus the company's product portfolio.

Competitive Analysis and Value Chain Assessment

The Turkish market is highly competitive, with a mix of established multinational corporations (MNCs) and strong local players like Abdi İbrahim, Bilim İlaç, and Nobel İlaç. Competitive analysis should cover:

  • Competitor Profiling: Detailed profiling of key players, including their product portfolios, R&D investments, manufacturing capacities, distribution channels, and market share across different therapeutic classes.
  • Supply Chain and Distribution: Mapping the supply chain, from Active Pharmaceutical Ingredient (API) sourcing and local manufacturing to distribution channels (wholesalers, pharmacies). A strong, resilient supply chain is critical given global logistics challenges.
  • R&D and Localization: Evaluating the level of R&D investment by competitors and the impact of government incentives for local production and technology transfer. The focus on local production is a critical factor for long-term success and favorable pricing.

The Feasibility Study: Stress-Testing the Business Model

The feasibility study translates the data from market research into a tangible assessment of the proposed pharmaceutical company's viability. This process rigorously evaluates the project from financial, technical, and operational perspectives.

Technical and Operational Feasibility

Establishing a pharmaceutical manufacturing facility is capital-intensive and subject to stringent standards. This phase must address:

  • Facility Requirements: Determining the optimal location for the manufacturing plant, considering proximity to raw material sources, labor, logistics hubs, and incentives in Organized Industrial Zones (OIZs). The study must specify the facility design and layout to ensure compliance with Turkish GMP and international standards.
  • Technology and Equipment: Specifying the necessary equipment for different dosage forms (e.g., solid, liquid, sterile injectables) and evaluating the cost and sourcing of these advanced technologies.
  • Supply Chain Planning: Developing a robust API sourcing strategy, including a balance of local and international suppliers, and establishing a quality control system for all raw materials.
  • Human Resources: Assessing the availability and cost of specialized labor, including pharmacists, chemists, qualified engineers, and R&D personnel.

Financial Viability and Risk Analysis

The financial assessment is critical for securing investment and must present a clear path to profitability. Key components include:

  • Capital Expenditure (CAPEX): A detailed breakdown of startup costs, including land acquisition, facility construction, equipment purchase, and regulatory licensing fees.
  • Operational Expenditure (OPEX): Forecasting recurring costs such as labor, utilities, raw materials, maintenance, and R&D spending. High inflation and currency volatility in Turkey necessitate conservative and stress-tested financial models.
  • Revenue Projections and Pricing Strategy: Generating realistic sales forecasts based on market share goals, product pricing (which is often government-controlled), and expected reimbursement rates.
  • Key Financial Indicators: Calculating the Net Present Value (NPV), Internal Rate of Return (IRR), and Payback Period to demonstrate the project's attractiveness to investors.
  • Risk Mitigation: Identifying core risks (e.g., regulatory delays, currency fluctuations, changes in reimbursement policy, and competitive entry) and developing clear mitigation strategies.

The Strategic Business Plan: A Roadmap for Execution

The business plan synthesizes the market research and feasibility study findings into a cohesive, actionable document. It serves as the company’s internal blueprint and the primary external tool for attracting investment and securing strategic partnerships. The plan for a Pharmaceutical Company in Turkey should be highly detailed, focusing on compliance and scalability.

  • Executive Summary: A concise, compelling overview of the opportunity, the proposed solution, and the projected financial returns.
  • Company and Product Description: Detailing the company’s legal structure, mission, and the specific product portfolio (generics, OTC, biologics) intended for the Turkish and export markets.
  • Market Analysis (The Core): Presenting the deep-dive research on the Turkish market, including the target patient population, competitive advantages, and the strategy for navigating the regulatory and pricing landscape.
  • Manufacturing and Operations Plan: Outlining the phased plan for facility construction, technology implementation, GMP certification, quality management system, and capacity utilization.
  • Sales and Marketing Strategy: Developing a strategy for engaging with key stakeholders, including physicians, pharmacists, hospitals, and the SGK. This must be compliant with strict pharmaceutical marketing regulations.
  • Financial Plan: Detailed five-year projections, including cash flow statements, income statements, balance sheets, and capital requirements.
  • Management Team: Highlighting the expertise of the team, especially in regulatory affairs, R&D, and local commercialization.

How Aviaan Can Be Your Strategic Partner in Turkey

Successfully launching a pharmaceutical company in Turkey is a complex undertaking that requires specialized expertise across regulatory, financial, and operational domains. Aviaan provides comprehensive advisory services to navigate this high-stakes environment.

Aviaan's team possesses a deep understanding of the Turkish healthcare and pharmaceutical sector, including the intricate web of TITCK regulations and SGK reimbursement mechanisms. They are equipped to conduct highly specialized market research, focusing on pharmacoeconomics, product portfolio gap analysis, and competitive benchmarking against both local giants and MNCs.

In the feasibility study phase, Aviaan offers robust financial modeling that accounts for Turkish-specific risks such as high inflation and Lira volatility. They provide a stress-tested financial roadmap, ensuring that the CAPEX and OPEX models are realistic and compliant with local tax and accounting standards. Aviaan's advisory extends to technical planning, helping to identify suitable sites for GMP-compliant facilities and connecting clients with local engineering and logistics partners. They ensure that the operational plan is scalable and efficient, meeting both domestic demand and export potential into MENA and CIS regions.

Finally, Aviaan is instrumental in translating all this complex data into an investor-ready business plan. They structure the document to clearly articulate the value proposition to local and international investors, with a focus on regulatory compliance, intellectual property protection, and sustainable long-term growth within the Turkish pharmaceutical value chain.

Case Study: Establishing a Biosimilar Manufacturing Hub in Turkey

A major international pharmaceutical group, based in Switzerland, sought to establish a dedicated biosimilar manufacturing and distribution hub to serve the rapidly growing Turkish and surrounding regional markets. The group recognized the high demand for cost-effective biologics in Turkey but was wary of the country's stringent regulatory processes, complex pricing system, and local content requirements. They engaged Aviaan for a full-scope project.

The Challenge and Aviaan's Intervention

The primary challenges were two-fold: first, securing the necessary TITCK approvals and GMP certification for a highly sensitive biologics facility, and second, developing a commercially viable pricing and market access strategy within the government-controlled SGK reimbursement system.

Aviaan initiated a specialized market research study on the biosimilars segment. The research identified that the highest-growth opportunity was in three specific therapeutic classes where patient demand was unmet and the government was actively incentivizing localization. The study provided granular data on the expected market entry timeline for competing biosimilars and established optimal pricing corridors for reimbursement.

In the feasibility study, Aviaan's financial modeling was crucial. Given the multi-million dollar CAPEX required for a biologics facility, the team created a dynamic financial model that included scenario analysis for a range of currency fluctuations, varying local content percentages (to secure better government incentives), and different SGK reimbursement rates. This model demonstrated a robust Internal Rate of Return (IRR) despite the high initial investment, making the project highly attractive to the parent company’s board. Operationally, Aviaan guided the client on selecting a site within an Industrial Zone near Ankara, offering tax benefits and proximity to key logistics routes. They advised on the necessary quality management system to ensure compliance with EU GMP and TITCK requirements simultaneously.

Conclusion

The establishment of a pharmaceutical company in Turkey represents a significant investment opportunity, driven by a large domestic market and its role as a regional export hub. Success hinges on a precise understanding of the country’s regulatory framework, an ability to navigate the unique pricing and reimbursement system, and a commitment to world-class manufacturing standards. The process of conducting detailed market research, a rigorous feasibility study, and creating a strategic business plan is non-negotiable. By leveraging the deep-seated knowledge and specialized advisory services of a partner like Aviaan, new entrants can effectively mitigate risks, optimize their operational strategy, and ensure a compliant, profitable, and sustainable foothold in the competitive Turkish pharmaceutical market.

Related posts

Market Research, Feasibility Study and Business Plan for Construction Materials Manufacturing in Turkey

Market Research, Feasibility Study and Business Plan for Clinic (variety of specialties)in Turkey

Market Research, Feasibility Study and Business Plan for Grocery Store in Turkey

Market Research, Feasibility Study and Business Plan for Medical Devices Manufacturer in Turkey

Market Research, Feasibility Study and Business Plan for Pharmaceutical Company in Turkey

Market Research, Feasibility Study and Business Plan for Mental Health Services in Turkey

Market Research, Feasibility Study and Business Plan for Software Development Company in Turkey

Market Research, Feasibility Study and Business Plan for Artificial Intelligence Company in Turkey

Market Research, Feasibility Study and Business Plan for Data Analytics Company in Turkey

Market Research, Feasibility Study and Business Plan for Agricultural Farm in Turkey

Talk to an Expert

Schedule a complimentary 30-minute discovery call to discuss your requirements.

By submitting, you agree to our Privacy Policy.

Table of Contents

Need Immediate Help?

Our advisory team is ready to assist you.

Let's Build Your Business Success Together

Our senior partners are available to evaluate your current financial structure and identify opportunities for optimization and risk reduction.

Sector Expertise

Our advisory assignments span a wide range of industries, including:

Healthcare
Hospitality
Restaurants & F&B
Retail
Technology & SaaS
Fintech
Real Estate
Manufacturing
Logistics
Education
Automotive
Consumer Products
Professional Services
Renewable Energy
E-commerce
Beauty & Wellness

Each sector requires different demand drivers, economics, competitive factors and valuation considerations. Our analysis is structured accordingly.

Industries We Serve

Tailored financial strategies for specialized sectors.

Real Estate

Healthcare

Manufacturing

Technology

Retail & E comm

Logistics

Services Offered by Aviaan

Feasibility Study

Independent verification of financial statements to ensure transparency and trust.

Business Plan

A comprehensive analysis to evaluate the commercial, technical, and financial viability of a proposed business or project before investment.

Business Valuation

An objective assessment of a company, asset, or investment to determine its fair market value for transactions, reporting, or strategic decisions.

Due Diligence

A detailed financial review to assess risks, validate performance, and ensure informed decision-making in transactions.

Accounting

End-to-end financial recording, reporting, and compliance services to maintain accurate books and support business decision-making.

Market Research

Launching a new venture, expanding into a new geography, raising capital, or entering a new segment, robust market research is critical.

Need Immediate Help?

Our advisory team is ready to assist you with your urgent financial queries.

Services Offered by Aviaan

Feasibility Study

Independent verification of financial statements to ensure transparency and trust.

LEARN MORE →

Business Plan

A comprehensive analysis to evaluate the commercial, technical, and financial viability of a proposed business or project before investment.

LEARN MORE →

Business Valuation

An objective assessment of a company, asset, or investment to determine its fair market value for transactions, reporting, or strategic decisions.

LEARN MORE →

Due Diligence

A detailed financial review to assess risks, validate performance, and ensure informed decision-making in transactions.

LEARN MORE →

Accounting

End-to-end financial recording, reporting, and compliance services to maintain accurate books and support business decision-making.

LEARN MORE →

Market Research

Launching a new venture, expanding into a new geography, raising capital, or entering a new segment, robust market research is critical.

LEARN MORE →

Ready to Speak with an Expert?

Partner with Aviaan Advisory today to unlock your business’s full potential. Our team of experts is here
to provide tailored solutions and guide you every step of the way.